20 May 2013
Keywords: osi, macugen, sees, strong, data, arvo, usa
Article | 15 May 2006
The USA's OSI Pharmaceuticals says that strong data were presented on Macugen (pegaptanib sodium injection), its drug for neovascular
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 May 2006
8 May 2006
17 May 2013
© 2013 thepharmaletter.com